ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,041 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselRhizen Pharmaceuticals AG
Rhizen Pharmaceuticals AG Logo
Verified· 2 sources

Rhizen Pharmaceuticals AG

Summary

About the company

The core activity of Rhizen Pharmaceuticals AG is the development and marketing of pharmaceuticals, particularly in the field of oncology (cancer treatment) and onco-supportive care. The company focuses on the discovery, development and commercialization of innovative pharmaceuticals that address multiple cancer indications. It has a deep pipeline of assets covering various oncology indications and has expertise in discovery, preclinical development, clinical development and regulatory affairs.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered4
Development of oncology medicines
Development of differentiated small-molecule medicines for oncology, including novel drug programs, preclinical development and clinical trials.
Development of anti-inflammatory medicines
Development of inflammation-focused drug programs, including oral and inhaled assets for further clinical development and different indications.
Partnerships and out-licensing
Partnerships, co-development, regional and global deals, out-licensing of developed assets, as well as support for CMC, clinical supply and commercialization.
Development of clinical drug programs
Clinical advancement of internal programs through Phase 1 and Phase 2 studies, including safety, efficacy and proof-of-concept studies.

Knowledge

No knowledge articles yet

Once Rhizen Pharmaceuticals AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Rhizen Pharmaceuticals AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Rhizen Pharmaceuticals AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Rhizen Pharmaceuticals AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Grosspeteranlage 29
4052 Basel
Opening hours
Mon
09:00 - 17:00
Tue
09:00 - 17:00
Wed
09:00 - 17:00
Thu
09:00 - 17:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-114.577.507
Founded
2008 · 18 years
Last commercial register change
June 25, 2025
Employees
51 to 100

Similar companies

MM
Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch
Basel
RS
Regeneron Switzerland GmbH
Basel
LT
LifeMine Therapeutics (Switzerland) GmbH
Basel
TA
Torqur AG
Basel
MR
Monte Rosa Therapeutics AG
Basel
BM
BeOne Medicines International GmbH
Basel
ST
Skyhawk Therapeutics Europe GmbH
Basel
FT
FoRx Therapeutics AG
Basel